Sodium Bicarbonate — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	IV	0.5-1 mEq/kg slow IV bolus; may repeat based on blood gas analysis	As needed based on acid-base status	Duration: Until acidosis corrected Notes: Dose should be calculated based on base deficit: mEq HCO3 = 0.3 x body weight (kg) x base deficit. Administer slowly over 15-30 minutes. Reassess blood gases frequently.
Dog	PO	10-20 mEq/kg/day divided q8-12h	q8-12h	Duration: As needed for urinary alkalinization Notes: For urinary alkalinization, adjust dose to maintain urine pH at desired level (e.g., 7.0-7.5).
Cat	IV	0.5-1 mEq/kg slow IV bolus; may repeat based on blood gas analysis	As needed based on acid-base status	Duration: Until acidosis corrected Notes: Use cautiously in cats with renal disease; monitor for fluid overload and hypernatremia.
Cat	PO	10-20 mEq/kg/day divided q8-12h	q8-12h	Duration: As needed for urinary alkalinization Notes: For chronic kidney disease, use with caution; monitor serum electrolytes.
Horse	IV	1-2 mEq/kg slow IV; may repeat based on blood gas analysis	As needed	Duration: Until acidosis corrected Notes: Administer slowly to avoid paradoxical CSF acidosis. Monitor serum potassium and calcium.
Horse	PO	100-200 g per horse per day (approximately 1-2 g/kg)	Once daily or divided	Duration: As needed Notes: For urinary alkalinization or chronic acidosis; monitor urine pH.
Cattle	IV	1-2 mEq/kg slow IV; may repeat based on blood gas analysis	As needed	Duration: Until acidosis corrected Notes: Commonly used in ruminal acidosis; monitor for hypernatremia and fluid overload.
Cattle	PO	100-200 g per animal per day (approximately 1-2 g/kg)	Once daily or divided	Duration: As needed Notes: For ruminal acidosis, oral administration may be less effective than IV; monitor response.
Small Ruminants	IV	1-2 mEq/kg slow IV	As needed	Duration: Until acidosis corrected Notes: Use cautiously; monitor for electrolyte imbalances.
Small Ruminants	PO	10-20 mEq/kg/day divided	q8-12h	Duration: As needed Notes: For urinary alkalinization or chronic acidosis.
Rabbit	IV	0.5-1 mEq/kg slow IV	As needed	Duration: Until acidosis corrected Notes: Use cautiously; rabbits are prone to GI stasis, and oral bicarbonate may be contraindicated.
Rabbit	PO	Not commonly used; may be used for urinary alkalinization at 1-2 mEq/kg q8-12h	q8-12h	Duration: As needed Notes: Monitor urine pH and serum electrolytes.
Bird/Poultry	IV	0.5-1 mEq/kg slow IV	As needed	Duration: Until acidosis corrected Notes: Use cautiously; monitor for fluid overload.
Bird/Poultry	PO	1-2 mEq/kg in drinking water or feed	Continuous or divided	Duration: As needed Notes: For urinary alkalinization or acidosis; ensure adequate water intake.
Exotic/Other	IV	0.5-1 mEq/kg slow IV	As needed	Duration: Until acidosis corrected Notes: Dose based on blood gas analysis if available.
Exotic/Other	PO	1-2 mEq/kg q8-12h	q8-12h	Duration: As needed Notes: For urinary alkalinization; monitor urine pH.

Clinical Indications & Species Uses

General Indications

Correction of metabolic acidosis
Urinary alkalinization
Adjunct in hyperkalemia management
Cardiopulmonary resuscitation

Dog (Canine)

Treatment of metabolic acidosis (e.g., diabetic ketoacidosis, lactic acidosis, renal tubular acidosis)
Alkalinization of urine to enhance excretion of weak acids (e.g., salicylate, phenobarbital) in toxicity cases
Management of hyperkalemia (as an adjunct to shift potassium intracellularly)
Cardiopulmonary resuscitation (to correct acidosis during cardiac arrest)

Cat (Feline)

Treatment of metabolic acidosis (e.g., chronic kidney disease, diabetic ketoacidosis)
Alkalinization of urine in cases of urate urolithiasis or to enhance excretion of certain toxins
Management of hyperkalemia (as an adjunct)
Cardiopulmonary resuscitation

Horse (Equine)

Treatment of metabolic acidosis (e.g., severe diarrhea, endurance exercise-associated acidosis)
Management of hyperkalemic periodic paralysis (as an adjunct to lower serum potassium)
Alkalinization of urine in certain toxicities

Cattle (Bovine)

Treatment of metabolic acidosis (e.g., ruminal acidosis, lactic acidosis, diarrhea in calves)
Management of hyperkalemia (e.g., in downer cows)
Alkalinization of urine in certain toxicities

Small Ruminants (Sheep / Goat)

Treatment of metabolic acidosis (e.g., ruminal acidosis, diarrhea)
Management of hyperkalemia
Alkalinization of urine in certain toxicities

Rabbit & Small Mammals

Treatment of metabolic acidosis (e.g., diarrhea, anorexia)

Avian & Poultry

Treatment of metabolic acidosis (e.g., lactic acidosis, heat stress)
Alkalinization of urine in certain toxicities

Exotic & Other Species

Treatment of metabolic acidosis in reptiles, small mammals, and other exotics as needed
Alkalinization of urine in cases of urate urolithiasis in reptiles

Pharmacology & Mechanism of Action

Drug Class: Alkalizing Agent | Pharmacological Group: Electrolyte and Acid-Base Modifier

Mechanism of Action: Sodium bicarbonate dissociates in water to provide bicarbonate ions (HCO3-) and sodium ions (Na+). The bicarbonate ion acts as a physiological buffer by combining with hydrogen ions (H+) to form carbonic acid (H2CO3), which then dissociates into water and carbon dioxide (CO2). CO2 is subsequently exhaled by the lungs. This process raises blood pH and corrects metabolic acidosis. Additionally, sodium bicarbonate increases urinary pH by increasing the filtered load of bicarbonate, which can enhance the excretion of weak acids and certain drugs (e.g., salicylates, phenobarbital).

Pharmacodynamics: The primary pharmacodynamic effect is the elevation of plasma bicarbonate concentration and blood pH. It also increases urinary pH, which can affect the ionization and excretion of various compounds. In cases of metabolic acidosis, administration of sodium bicarbonate can improve cardiac contractility, restore vascular responsiveness to catecholamines, and reduce the adverse effects of acidemia on cellular function. However, excessive administration can lead to metabolic alkalosis, hypernatremia, and fluid overload.

⚡ Pharmacokinetics Summary

Absorption: When administered orally, sodium bicarbonate is rapidly absorbed from the gastrointestinal tract. When administered intravenously, it is immediately available in the systemic circulation.

Distribution: Bicarbonate distributes throughout the extracellular fluid and can cross cell membranes to some extent. It also distributes into the cerebrospinal fluid, but equilibration is slower. The apparent volume of distribution is approximately 50% of body weight.

Metabolism: Bicarbonate is not metabolized per se; it participates in the carbonic acid-bicarbonate buffer system and is converted to CO2 and water via carbonic anhydrase. The CO2 is then eliminated by the lungs.

Excretion: Bicarbonate is primarily excreted by the kidneys. The renal threshold for bicarbonate reabsorption is approximately 24-26 mEq/L in dogs and cats. When plasma bicarbonate exceeds this threshold, excess bicarbonate is excreted in the urine, increasing urinary pH.

Half-Life: The half-life is variable and depends on the acid-base status and renal function. In healthy animals, the half-life is approximately 1-2 hours, but it may be prolonged in renal impairment.

Bioavailability: Oral bioavailability is high, but the onset of action is slower compared to intravenous administration. The oral route is less predictable due to gastric neutralization.

Protein Binding: Bicarbonate is not significantly protein-bound.

Available Formulations & Strengths

Injectable Solution 4.2% (0.5 mEq/mL), 7.5% (0.89 mEq/mL), 8.4% (1 mEq/mL) (IV)

Oral Tablet 325 mg (3.8 mEq), 650 mg (7.7 mEq) (PO)

Oral Powder Various bulk powders (PO)

Oral Solution Various concentrations (PO)

Contraindications & Clinical Warnings

Contraindications:

Metabolic alkalosis
Respiratory alkalosis
Hypocalcemia (may precipitate tetany)
Hypernatremia
Edematous states (e.g., congestive heart failure, renal failure with oliguria/anuria)
Patients with inadequate ventilation (risk of CO2 retention)
Known hypersensitivity to sodium bicarbonate

Warnings & Clinical Precautions:

Use with extreme caution in patients with renal impairment, heart failure, or conditions predisposing to fluid overload.
Rapid IV administration can cause paradoxical cerebrospinal fluid acidosis and hypocalcemia.
Monitor serum electrolytes (sodium, potassium, calcium) and blood gases frequently during therapy.
Avoid extravasation as it can cause tissue necrosis.
In food animals, observe withdrawal times.
Do not mix with calcium-containing solutions (precipitation).
Use with caution in neonates and geriatric patients.

Adverse Effects & Reactions

Common:

Metabolic alkalosis
Hypernatremia
Fluid overload
Hypokalemia (due to intracellular shift)
Hypocalcemia (due to increased protein binding and precipitation)

Serious / Severe:

Paradoxical cerebrospinal fluid acidosis
Tissue necrosis at injection site (if extravasation)
Cardiac arrhythmias (due to electrolyte imbalances)
Cerebral edema (in severe hypernatremia)
Tetany (due to hypocalcemia)

Rare:

Gastric rupture (if oral administration in ruminants with ruminal acidosis)
Metabolic alkalosis with compensatory hypoventilation
Osmotic demyelination syndrome (with rapid correction of acidosis)

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Calcium-containing IV solutions	Precipitation of calcium carbonate; do not mix.	High
Catecholamines (e.g., epinephrine)	Sodium bicarbonate may reduce the effectiveness of catecholamines; also, alkalosis can increase the risk of arrhythmias.	Moderate
Quinidine	Increased risk of quinidine toxicity due to increased protein binding and decreased excretion.	Moderate
Salicylates	Increased renal excretion of salicylates due to urinary alkalinization; may reduce salicylate efficacy.	Moderate
Phenobarbital	Increased renal excretion of phenobarbital due to urinary alkalinization.	Moderate
Lithium	Increased lithium excretion with urinary alkalinization; may reduce lithium levels.	Moderate
Potassium supplements	Sodium bicarbonate can cause hypokalemia; concurrent use may require dose adjustment.	Mild
Diuretics (e.g., furosemide)	Increased risk of hypokalemia and metabolic alkalosis.	Moderate

Overdose & Toxicity Management

Signs of Toxicity:

Metabolic alkalosis
Hypernatremia
Hypokalemia
Hypocalcemia
Seizures
Tetany
Cardiac arrhythmias
Cerebral edema
Respiratory depression

Emergency Treatment Protocol: Discontinue sodium bicarbonate administration. Correct fluid and electrolyte imbalances: administer 0.9% NaCl to correct hypernatremia, potassium chloride to correct hypokalemia, and calcium gluconate if hypocalcemia is symptomatic. In severe alkalosis, consider acetazolamide to increase bicarbonate excretion. Monitor blood gases and electrolytes closely. Provide supportive care as needed.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days🥚 Eggs: 0 days

Sodium bicarbonate is generally considered to have zero withdrawal times in food animals when used appropriately. However, it is not a regulated drug, but extra-label use may require veterinary oversight. Always follow local regulations.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature (20-25°C, excursions permitted to 15-30°C).

Handling & Special Conditions: Keep container tightly closed. Protect from moisture. Do not freeze injectable solutions.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Approved for use in veterinary medicine for various species; however, many formulations are not specifically FDA-approved for animals and are used extra-label.

Extra-Label (Off-Label) Use: Sodium bicarbonate is an over-the-counter drug in many countries, but extra-label use in food animals must comply with AMDUCA regulations in the US. It is not a controlled substance.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Sodium bicarbonate is a fundamental agent for correcting metabolic acidosis and alkalinizing urine. In veterinary practice, it is commonly used in emergency settings for diabetic ketoacidosis, severe diarrhea, and cardiac arrest. However, its use should be guided by blood gas analysis to avoid overcorrection. In ruminants, oral administration may be less effective due to ruminal buffering, and IV administration is preferred for acute acidosis. In small animals, oral bicarbonate is used for chronic urinary alkalinization (e.g., urate urolithiasis). Always monitor serum electrolytes and acid-base status during therapy. Use with caution in patients with renal or cardiac disease. For food animals, withdrawal times are generally zero, but check local regulations.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)